LNTH vs SRPT · P/E 23, rev $1.53B vs rev $1.90B
Lantheus Holdings Inc (LNTH) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Lantheus Holdings Inc (LNTH) is a drug manufacturers - specialty & generic company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported LNTH revenue for 2024-12-31 was $1.53B. Net income was $312.4M. Revenue was up 18.3% from 2023-12-31 to 2024-12-31. LNTH currently screens at market cap $5.56B and trailing P/E 22.9.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
LNTH currently screens at market cap $5.56B and trailing P/E 22.9. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the LNTH and SRPT stock pages for the full models.
Not investment advice.